Mikawa, M Wang, H Guo, L Liu, R Marik, J Yoshikazu Takada Lam, K Lau, D
Published in
Molecular Cancer Therapeutics
Using the "one-bead one-peptide" combinatorial technology, a library of random cyclic octapeptides and nonapeptides, consisting of natural and unnatural amino acids, was synthesized on polystyrene beads. This library was used to screen for peptides that promoted attachment and proliferation of bronchioloalveolar carcinoma cells (H1650), employing a...
Xiao, Wenwu Wang, Yan Lau, Edmond Y Luo, Juntao Yao, Nianhuan Shi, Changying Meza, Leah Tseng, Harry Maeda, Yoshiko Kumaresan, Pappanaicken
...
Published in
Molecular cancer therapeutics
The αvβ3 integrin, expressed on the surface of various normal and cancer cells, is involved in numerous physiologic processes such as angiogenesis, apoptosis, and bone resorption. Because this integrin plays a key role in angiogenesis and metastasis of human tumors, αvβ3 integrin ligands are of great interest to advances in targeted therapy and can...
Wang, Y Xiao, W Zhang, Y Meza, L Tseng, H Yoshikazu Takada Ames, Jb Lam, Ks
Published in
Molecular Cancer Therapeutics
We have previously reported the use of one-bead-one-compound (OBOC) combinatorial technology to develop a disulfide cyclic, Arg-Gly-Asp-containing octapeptide LXW7 (cGRGDdvc), that targets αvβ3 integrin with high affinity and specificity. αvβ3 integrin is known to be overexpressed in many cancers and in tumor vasculature, and it has been establishe...